Urologic Cancer Care

When you’re a patient at Providence, we don’t just treat your urologic cancer – we treat you. We use the most advanced treatments to create a highly personalized care plan. We also support you and your loved ones with a full range of services throughout your entire cancer journey. The result is effective, whole-person care for your body, mind and spirit.

Find a Location

Why Choose Us for Urologic Cancer Care?

At Providence, we see the life in you. Together, let’s finish cancer – so you don’t have to miss any of life’s special moments.

Doctor smiling at patient

No two patients, or their treatment plans, are alike. This is why, at Providence, we take a highly personalized approach to your urologic cancer care. You’ll experience this through our multidisciplinary tumor boards, where your oncology team collaborates with other cancer care experts about your specific diagnosis. We also offer a Providence Molecular Tumor Board, where we evaluate your genomic and clinical information to find the best genetically matched treatment for you. Your oncology team will work with you directly to design a treatment plan that fits your personal needs. It’s an approach that combines leading-edge treatment with the compassionate care Providence is known for. Why? Because we know this results in the best outcomes.

As a patient, you’ll be supported through your entire cancer journey by a multidisciplinary cancer care team. You’ll be treated by one of more than 200 expert urologists, along with board-certified medical oncologists and radiation oncologists. If surgery is required, our world-class surgeons use the most advanced techniques. It’s a team-based approach to urologic cancer. Your cancer care team may also include oncology nurse navigators, sexual counselors and other cancer specialists. We also provide you and your family with a full range of support services well beyond conventional treatment, from genetic counseling and education to nutrition and pain management.

Learn more about the experts who make up our multidisciplinary cancer care teams.

Cancer doesn’t discriminate, but access to great urologic cancer care hasn’t always been the same for everyone. At Providence, we are deeply committed to making sure every patient we treat has access to the best cancer care. We offer various location-specific services to help our patients receive equitable care, such as translation for non-English-speaking patients, telehealth and transportation assistance. We value, respect and support the racial, ethnic, religious, spiritual, gender, and sexual identities of each member of our diverse communities, and we welcome all patients, regardless of their ability to pay. We aim to make sure every patient is treated equally and with dignity – whoever you are, and wherever you’re at.

As a patient at Providence, you have access to the largest community-based cancer network in the United States. Being part of a collaborative network means that your local urologic cancer care team shares knowledge and experience with other world-class clinicians across 51 hospitals in seven states. The extent and power of our network is one of the reasons more than 7,000 new urologic cancer patients, and 50,000 new cancer patients, choose Providence each year.

Providence is well known for offering options – and hope – to patients seeking the most advanced procedures and therapies to treat urologic cancers. For instance, Providence researchers are currently testing how new systemic therapies and treatments improve prostate cancer patient outcomes. As a patient, you have the opportunity to participate in one of over 40 clinical trials happening across the Providence network for urologic cancer treatment, such as those testing new drug combinations for advanced kidney cancer.

About Urologic Cancer

Urologic cancers form in the urinary tract organs. Some urologic cancers, such as bladder cancer, can occur in both men and women, while others, such as testicular cancer, are gender specific. The expert oncology teams at Providence use the most effective therapies to treat patients with every type of urologic cancer and its related conditions, including:

Testing and Diagnostics

Male doctor with male patient

Diagnostic tools help our cancer clinicians determine which therapies will work best for each patient, based on many factors like cancer type and the genetic or molecular profile of the tumor. Your doctors will use multiple advanced diagnostic and prognostic tools to help design your individualized treatment plan. Depending on your case, this may include one or more of the following:


Personalized Treatment for Urologic Cancer

We take a team approach to your urologic cancer treatment because we know this offers the best success in controlling and curing cancer. Your multidisciplinary cancer care team will work with you to design an individualized cancer care plan, from diagnosis to post-treatment support. We offer many different therapies across our Providence locations. Depending on your condition, your personal care plan may include one or more of the following:

Systemic Therapies Radiation Therapies
Systemic Therapies

Systemic therapies travel through the bloodstream and affect cells in other body parts. They are used for patients whose cancer has spread to other areas of the body or if there’s a high risk of spread. Sophisticated genetic analysis allows us to target therapies to specific DNA mutations that cause cancer cells to develop and grow. Systemic therapies include:

Chemotherapy is the systemic use of cytotoxic chemicals to kill cancer cells. Today there are many medications (e.g., biological medications, immune treatments, targeted therapies) that do not fit the classic definition of chemotherapy yet are often included in this category.

Clinical trials represent research protocols that include the use of new drugs or drug combinations in a specific clinical situation.

Hormone therapy is the use of drugs that inhibit the production or block the effect of certain hormones (usually sex hormones), helping to control cancer-cell growth.

Immunotherapy uses drugs to allow the body’s own immune system to more effectively find and destroy cancer cells.

Molecularly targeted therapy is the use of drugs that are molecularly targeted at a genetic mutation that has allowed the cancer to grow. This therapy enables personalized treatments for patients who carry certain genetic mutations or abnormalities.

Radioligand therapy is a systemic therapy in which a radioisotope is attached to an antibody directed at a specific cancer cell. This targeted treatment delivery maximizes cancer control while minimizing side effects.

Radiation therapy uses high-energy radiation from a source like X-rays or photons to kill cancer cells or shrink tumors. It may be part of a treatment plan that also includes systemic therapies and/or surgery. Radiation is sometimes used to help ease a patient’s pain or discomfort. Radiation therapies include:

Brachytherapy is an approach to delivering radiation treatment from a source implanted inside the body. These sources may be placed either permanently or temporarily at the tumor site.

By delivering radiation directly into a tumor, this technique spares the surrounding normal tissue any exposure to radiation and the side effects that it may bring.

This advanced procedure requires a sophisticated facility and equipment, along with highly specialized physicians and support. It is available at some Providence locations.

Interstitial high-dose rate (HDR) brachytherapy is a specialized brachytherapy technique in which rapidly emitting radiation sources are placed briefly inside the body through a needle catheter to irradiate the target tumor.

By delivering high-dose radiation directly into a tumor, this technique can reduce the number of treatments needed for a patient. The surrounding normal tissue is spared exposure to radiation and the side effects that it may bring.

This advanced procedure requires a sophisticated facility and equipment, along with highly specialized physicians and support. It is available at some Providence locations.

Intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) are advanced types of radiation therapies. IMRT uses advanced technology to manipulate the radiation beams to conform to the shape of a tumor. VMAT is a subtype of IMRT in which the machine actively delivers radiation beams while moving in an arc around the patient.

This method of radiation delivery offers next-generation capabilities. The arc-based therapy provided via VMAT delivers high doses of radiation to more focused areas, reducing side effects and the overall treatment time for the patient. This treatment is particularly effective at treating several types of cancer while at the same time reducing toxicity and harm to vital organs.

This procedure is one of several new ways to deliver radiation therapy. It requires a sophisticated facility and equipment, along with highly specialized physicians. It is available at some Providence locations.

Stereotactic radiation (SABR/SBRT) is a group of treatments that includes stereotactic body radiation therapy (SBRT) and stereotactic ablative radiation (SABR) – both of which are adaptations of stereotactic radiosurgery (SRS) – for the treatment of targets in the body, but outside the brain. Similar to SRS, these techniques deliver very high doses of radiation using sophisticated motion management and patient immobilization techniques.

The number of radiation treatments is minimal and may range from one to five treatments delivered over one to two weeks.

This procedure is one of several new ways to deliver radiation therapy. It requires a sophisticated facility and equipment, along with highly specialized physicians. It is available at some Providence locations.

Radiopharmaceuticals (Lu-177) is a radioisotope that is combined with a delivery molecule to specifically target a type of cancer cell in some neuroendocrine tumors and prostate cancers. This radiopharmaceutical compound simulates the action of a naturally occurring substance and binds to cancer cells. This interaction slows the growth of cancer cells, while at the same time working to destroy them using a radioactive particle inside the cell to damage the cancer cells’ DNA.

The elegance of this therapy lies in its ability to bind the medication directly to cancer cells and to apply radiation from inside the cancer cell – thus delivering a potent dose that does not penetrate very far, thereby sparing normal adjacent healthy cells.

This procedure is one of several new ways to deliver radiation therapy intravenously. It requires a sophisticated facility and equipment, along with highly specialized and licensed physicians. It is available at some Providence locations.

Three-dimensional conformal radiation therapy (3DCRT) is a radiation planning and treatment technique in which three-dimensional (3D) imaging enables improved targeting for radiation treatment. 3D planning with CT imaging makes radiation treatment much more conformal, or tailored to the target.

Find Urologic Cancer Care Close to You

Accreditations

We are proud to see our dedication to our cancer patients recognized by some of the most well-respected programs and institutions in the United States. Several of our Providence locations have achieved the following accreditations:

Meet the Team

At Providence, you'll have access to a vast network of dedicated and compassionate providers who offer personalized care by focusing on treatment, prevention and health education.

Female doctor wearing mask, doctors in background
Senior woman looking hopeful as she gazes out window

Find Clinical Trials

Are you looking for a clinical trial for yourself or for a patient? We’d love to help you find one!

Research and Clinical Trials

Find Care

Expert Tips and Advice for Cancer

Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says  
Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice
Leadership change at Providence Cancer Institute, #FINISHCANCER goal remains
11/14/2024
R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.
2024 SITC Meeting: A glimpse of recent advancements in immunotherapy
11/19/2024
The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.
Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma
10/30/2024
New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.
Read More Articles